ClinicalTrials.gg

Program

bemnifosbuvir

Also written as “AT-527”, “Bemnifosbuvir (BEM)” and “AT-527 + digoxin”.

Its studies are mostly in Hepatitis C, Chronic · COVID-19 · Renal Insufficiency, led by 2 companies.

Furthest: phase 3, since Nov 26, 202226 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Atea Pharmaceuticals240 open or runningphase 3since Nov 26, 2022Jul 13, 2017none ahead
Hoffmann-La Roche20 open or runningphase 3since May 10, 2021Jan 12, 2021none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 11 studies since Jul 13, 2017.

  1. Oct 28, 2021Phase 1 study in Healthy Volunteers StudyAtea Pharmaceuticals · NCT05137626 · 29 enrolled · Canada
  2. Nov 16, 2021Phase 1 study in Healthy Volunteer StudyAtea Pharmaceuticals · NCT05154123 · 29 enrolled · Canada
  3. Feb 16, 2022Phase 1 study in Healthy Volunteer StudyAtea Pharmaceuticals · NCT05256732 · 136 enrolled · Canada
  4. Oct 26, 2022Phase 1 study in Renal InsufficiencyAtea Pharmaceuticals · NCT05618314 · 36 enrolled · Canada
  5. Nov 26, 2022Phase 3 study in COVID-19Atea Pharmaceuticals · NCT05629962 · 2,285 enrolled · United States, Argentina, Brazil and more
  6. Jan 24, 2023Phase 1 study in Healthy VolunteerAtea Pharmaceuticals · NCT05724693 · 39 enrolled · United States
  7. Feb 9, 2023Phase 1 study in Healthy Volunteer StudyAtea Pharmaceuticals · NCT05731843 · 32 enrolled · Canada
  8. Apr 20, 20232 phase 1 studies in Healthy Volunteer StudyAtea Pharmaceuticals · NCT05905497, NCT05905484
  9. Jun 6, 2023Phase 2 study in Hepatitis C, ChronicAtea Pharmaceuticals · NCT05904470 · 275 enrolled · United States, Brazil, Canada and more
  10. Jan 2, 2024Phase 1 study in Healthy Volunteer StudyAtea Pharmaceuticals · NCT06204679 · 42 enrolled · United States
  11. Mar 24, 2025Phase 1 study in Renal InsufficiencyAtea Pharmaceuticals · NCT06911320 · 28 enrolled · United States
  12. May 19, 2025Phase 1 study in Healthy Volunteer StudyAtea Pharmaceuticals · NCT07007806 · 20 enrolled · United States
  13. Nov 19, 2025Phase 1 study in Healthy Volunteer StudyAtea Pharmaceuticals · NCT07272889 · 24 enrolled · Canada
  14. Dec 18, 2025Phase 1 study in Healthy Volunteer StudyAtea Pharmaceuticals · NCT07314346 · 30 enrolled · United States

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 26 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07314346Healthy Volunteer Study · United States1CompletedAtea PharmaceuticalsJul 23, 202630
NCT07272889Healthy Volunteer Study · Canada1CompletedAtea PharmaceuticalsFeb 17, 202624
NCT07007806Healthy Volunteer Study · United States1CompletedAtea PharmaceuticalsJun 28, 202520
NCT06911320Renal Insufficiency · United States1CompletedAtea PharmaceuticalsApr 30, 202628
NCT06204679Healthy Volunteer Study · United States1CompletedAtea PharmaceuticalsAug 25, 202442
NCT05904470Hepatitis C, Chronic · United States, Brazil, Canada and more2CompletedAtea PharmaceuticalsDec 9, 2024275
NCT05905497Healthy Volunteer Study · United States1CompletedAtea PharmaceuticalsMay 19, 202314
NCT05905484Healthy Volunteer Study · Canada1CompletedAtea PharmaceuticalsMay 31, 202335
NCT05731843Healthy Volunteer Study · Canada1CompletedAtea PharmaceuticalsMar 15, 202332
NCT05724693Healthy Volunteer · United States1CompletedAtea PharmaceuticalsApr 23, 202439
NCT05629962COVID-19 · United States, Argentina, Brazil and more3CompletedAtea PharmaceuticalsApr 25, 20242,285
NCT05618314Renal Insufficiency · Canada1CompletedAtea PharmaceuticalsJun 15, 202436
NCT05256732Healthy Volunteer Study · Canada1CompletedAtea PharmaceuticalsAug 23, 2022136
NCT05154123Healthy Volunteer Study · Canada1CompletedAtea PharmaceuticalsDec 23, 202129
NCT05137626Healthy Volunteers Study · Canada1CompletedAtea PharmaceuticalsDec 12, 202129
NCT05004415Healthy Volunteer Study · United States1CompletedAtea PharmaceuticalsAug 12, 20216
NCT04889040COVID-19 · Argentina, Belgium, Brazil and more3TerminatedHoffmann-La RocheDec 2, 2021216
NCT04877769Healthy Volunteer Study · United Kingdom1CompletedAtea PharmaceuticalsAug 31, 202124
NCT04865445Healthy Volunteer Study · Canada1CompletedAtea PharmaceuticalsMay 15, 202124
NCT04784000Healthy Volunteer Study · Canada1CompletedAtea PharmaceuticalsApr 10, 202120
NCT04711187Healthy Volunteer Study · Canada1CompletedAtea PharmaceuticalsSep 15, 202181
NCT04709835COVID-19 · Canada, Greece, Ireland and more2CompletedHoffmann-La RocheSep 17, 2021104
NCT04396106COVID-19 · United States, Argentina, Belgium and more2TerminatedAtea PharmaceuticalsJan 10, 202283
NCT04309734Hepatitis C · Belgium2WithdrawnAtea PharmaceuticalsJun 20220
NCT04019717Hepatitis C · Belgium, Mauritius, Moldova, Republic of2CompletedAtea PharmaceuticalsJan 29, 202010
NCT03219957Hepatitis C, Chronic · Belgium, Moldova, Republic of1CompletedAtea PharmaceuticalsJun 20, 201888

How it is read

Names in the registry

  • “AT-527”, 10 entries
  • “Bemnifosbuvir (BEM)”, 4 entries
  • “AT-527 + digoxin”, 2 entries
  • “AT-527 550 mg + midazolam”, 2 entries
  • “Buprenorphine/Naloxone + BEM/RZR”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.